Ra Medical Systems reports Q1 results
- Ra Medical Systems press release (NYSE:RMED): Q1 net loss was $66.4M and cash used by operations was $12.1M, which includes a $5.0M cash payment associated with a legacy settlement.
- Cash and cash equivalents on March 31, 2023, were $12.2M. Cash and cash equivalents were approximately $8.6M as of May 30, 2023.
- Revenue of $0.08M (vs. 9K Y/Y).